We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Molina Healthcare, Inc.’s (MOH - Free Report) second-quarter 2019 adjusted earnings of $3.11 per share surpassed the Zacks Consensus Estimate by 21.5%. Moreover, the bottom line improved 38% year over year, mainly on the back of lower expenses and the Meridian buyout.
Also, for the quarter under review, total revenues of $4.1 billion came ahead of the Zacks Consensus Estimate by 2.9%. However, the top line declined 14% year over year, mainly due to lower Medicaid membership and resizing of the Florida Medicaid contract as well as the exiting all but two Florida regions in 2018.
Quarterly Operational Update
The company’s net income totaled $196 million, down 3% year over year.
Total operating expenses decreased about 13.5% year over year to $3.9 billion. This improvement was attributable to lower medical care costs and no health insurer fees plus cost of service revenues.
For the second quarter, medical care cost was down 10% year over year to nearly $3.9 billion.
Molina Healthcare’s interest expenses dropped 31.3% year over year to $22 million due to constant payment of debts.
The total membership by Government Program for 2019 stands at 3.3 billion, down 17% year over year.
During the second quarter, Molina Healthcare received $345 million of dividends from regulated health plan subsidiaries.
Molina Healthcare, Inc Price, Consensus and EPS Surprise
As of Jun 30, 2019, Molina Healthcare’s cash and cash equivalents saw a reduction of 20.3% to $2.2 billion from the level at year-end 2018.
Total assets fell 6.5% from 2018 end to $6.7 billion.
The company’s shareholder equity improved nearly 5.4% from the figure at year-end 2018 to $1.7 billion.
For the first half of 2019, net cash outflow from operating activities stands at $156 million due to the government payment timing.
2019 Guidance
Following second-quarter results, the company hiked its 2019 outlook. It now expects its earnings in the range of 11.20-$11.50 per share, up from the prior estimate of $10.50 to $11.
Among other players from the medical sector having reported second-quarter earnings so far, the bottom-line results of UnitedHealth Group Incorporated (UNH - Free Report) , Anthem Inc. and Centene Corporation (CNC - Free Report) outpaced the respective Zacks Consensus Estimate.
More Stock News: This Is Bigger than the iPhone!
It could become the mother of all technological revolutions. Apple sold a mere 1 billion iPhones in 10 years but a new breakthrough is expected to generate more than 27 billion devices in just 3 years, creating a $1.7 trillion market.
Zacks has just released a Special Report that spotlights this fast-emerging phenomenon and 6 tickers for taking advantage of it. If you don't buy now, you may kick yourself in 2020.
Image: Bigstock
Molina Healthcare (MOH) Q2 Earnings Beat Estimates, Rise Y/Y
Molina Healthcare, Inc.’s (MOH - Free Report) second-quarter 2019 adjusted earnings of $3.11 per share surpassed the Zacks Consensus Estimate by 21.5%. Moreover, the bottom line improved 38% year over year, mainly on the back of lower expenses and the Meridian buyout.
Also, for the quarter under review, total revenues of $4.1 billion came ahead of the Zacks Consensus Estimate by 2.9%. However, the top line declined 14% year over year, mainly due to lower Medicaid membership and resizing of the Florida Medicaid contract as well as the exiting all but two Florida regions in 2018.
Quarterly Operational Update
The company’s net income totaled $196 million, down 3% year over year.
Total operating expenses decreased about 13.5% year over year to $3.9 billion. This improvement was attributable to lower medical care costs and no health insurer fees plus cost of service revenues.
For the second quarter, medical care cost was down 10% year over year to nearly $3.9 billion.
Molina Healthcare’s interest expenses dropped 31.3% year over year to $22 million due to constant payment of debts.
The total membership by Government Program for 2019 stands at 3.3 billion, down 17% year over year.
During the second quarter, Molina Healthcare received $345 million of dividends from regulated health plan subsidiaries.
Molina Healthcare, Inc Price, Consensus and EPS Surprise
Molina Healthcare, Inc price-consensus-eps-surprise-chart | Molina Healthcare, Inc Quote
Financial Update
As of Jun 30, 2019, Molina Healthcare’s cash and cash equivalents saw a reduction of 20.3% to $2.2 billion from the level at year-end 2018.
Total assets fell 6.5% from 2018 end to $6.7 billion.
The company’s shareholder equity improved nearly 5.4% from the figure at year-end 2018 to $1.7 billion.
For the first half of 2019, net cash outflow from operating activities stands at $156 million due to the government payment timing.
2019 Guidance
Following second-quarter results, the company hiked its 2019 outlook. It now expects its earnings in the range of 11.20-$11.50 per share, up from the prior estimate of $10.50 to $11.
Zacks Rank
Molina Healthcare sports a Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.
Releases From the Medical Sector
Among other players from the medical sector having reported second-quarter earnings so far, the bottom-line results of UnitedHealth Group Incorporated (UNH - Free Report) , Anthem Inc. and Centene Corporation (CNC - Free Report) outpaced the respective Zacks Consensus Estimate.
More Stock News: This Is Bigger than the iPhone!
It could become the mother of all technological revolutions. Apple sold a mere 1 billion iPhones in 10 years but a new breakthrough is expected to generate more than 27 billion devices in just 3 years, creating a $1.7 trillion market.
Zacks has just released a Special Report that spotlights this fast-emerging phenomenon and 6 tickers for taking advantage of it. If you don't buy now, you may kick yourself in 2020.
Click here for the 6 trades >>